Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by TimeScapeon Dec 18, 2023 6:37pm
254 Views
Post# 35790818

RE:RE:THEY LOST MONEY YET AGAIN

RE:RE:THEY LOST MONEY YET AGAINYou can't analyze a company like this on net income - has to be on revenue, EBITDA and cash flow.   They have more than $11,000,000 a quarter (US$) in depreciation/amortization which greatly distorts the net income figure.

Great to see the strong revenue and EBITDA growth and the EBITDA % up to 23.5% for the quarter.  Cash flow of $40.5 million US$ for the year is excellent for company with a $244 million Cdn market cap.  The EBITDA for the year works out roughly $67.9 million Cdn, so the stock is trading at roughly 3.6 times trailing EBITDA, very cheap compared to the very strong EBITDA growth rate. And if you annualize the Q4 EBITDA, the stock is trading at just over 3 times. Good to see the bad debts expense cut almost in half.  Results look very good to me.
<< Previous
Bullboard Posts
Next >>